Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

Published:2005-01-13 Issue:5 Volume:12 Page:437-445
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Galanis E,Okuno S H,Nascimento A G,Lewis B D,Lee R A,Oliveira A M,Sloan J A,Atherton P,Edmonson J H,Erlichman C,Randlev B,Wang Q,Freeman S,Rubin J

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3302436.pdf

Reference31 articles.

1. Barker DD, Berk AJ . Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 1987; 156: 107–121.

2. Dobner T, Horikoshi N, Rubsenwolf S, Shenk T . Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science (Wash. DC) 1996; 272: 1470–1473.

3. Bischoff JR et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science (Wash. DC) 1996; 274: 373–376.

4. Harada J, Berk A . p53-independent and -dependent requirements for E1B-55 kD in adenovirus type 5 replication. J Virol 1999; 73: 5333–5344.

5. Rothmann T et al. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol 1998; 72: 9470–9478.

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation of oncolytic viruses in sarcoma;Molecular Therapy: Oncology;2024-09

2. Oncolytic Activity of Sindbis Virus with the Help of GM-CSF in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-06-29

3. The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?;Molecular Therapy - Oncolytics;2023-09

4. Review of Safety Data for Adenovirus 5 as a Delivery Vector for Intratumoral Cancer Gene Therapy;Human Gene Therapy;2023-04-01

5. Gene therapy as a treatment of oral cancer: An insight;Journal of Oral and Maxillofacial Pathology;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3